Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial

OBJECTIVE: To assess if 12 novel circulating biomarkers, when added to ‘standard predictors’ available in general practice, could improve the 10-year prediction of cardiovascular events and mortality in patients with stable coronary heart disease. DESIGN: The patients participated as placebo receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkel, Per, Jakobsen, Janus Christian, Hilden, Jørgen, Jensen, Gorm Boje, Kjøller, Erik, Sajadieh, Ahmad, Kastrup, Jens, Kolmos, Hans Jørn, Iversen, Kasper Karmark, Bjerre, Mette, Larsson, Anders, Ärnlöv, Johan, Gluud, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443269/
https://www.ncbi.nlm.nih.gov/pubmed/32819979
http://dx.doi.org/10.1136/bmjopen-2019-033720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443269/
https://www.ncbi.nlm.nih.gov/pubmed/32819979
http://dx.doi.org/10.1136/bmjopen-2019-033720

Ejemplares similares